176 results on '"Pluijm, Saskia M. F."'
Search Results
2. Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study
- Author
-
de Beijer, Ismay A. E., Hardijzer, Emma C., Haupt, Riccardo, Grabow, Desiree, Balaguer, Julia, Bardi, Edit, Cañete Nieto, Adela, Ciesiūniene, Audronė, Düster, Vanessa, Filbert, Anna-Liesa, Gsell, Hannah, Kapitančukė, Monika, Ladenstein, Ruth, Langer, Thorsten, Muraca, Monica, van den Oever, Selina R., Prikken, Sofie, Rascon, Jelena, Tormo, Maria Teresa, Uyttebroeck, Anne, Vercruysse, Gertrui, van der Pal, Helena J. H., Kremer, Leontien C. M., and Pluijm, Saskia M. F.
- Published
- 2023
- Full Text
- View/download PDF
3. Correction: Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study
- Author
-
de Beijer, Ismay A. E., Hardijzer, Emma C., Haupt, Riccardo, Grabow, Desiree, Balaguer, Julia, Bardi, Edit, Nieto, Adela Cañete, Ciesiūniene, Audronė, Düster, Vanessa, Filbert, Anna-Liesa, Gsell, Hannah, Kapitančukė, Monika, Ladenstein, Ruth, Langer, Thorsten, Muraca, Monica, van den Oever, Selina R., Prikken, Sofie, Rascon, Jelena, Tormo, Maria Teresa, Uyttebroeck, Anne, Vercruysse, Gertrui, van der Pal, Helena J. H., Kremer, Leontien C. M., and Pluijm, Saskia M. F.
- Published
- 2024
- Full Text
- View/download PDF
4. Childhood cancer survivorship care during the COVID-19 pandemic: an international report of practice implications and provider concerns
- Author
-
van den Oever, Selina R., Pluijm, Saskia M. F., Skinner, Rod, Glaser, Adam, Mulder, Renée L., Armenian, Saro, Bardi, Edit, Berger, Claire, Ehrhardt, Matthew J., Gilleland Marchak, Jordan, Haeusler, Gabrielle M., Hartogh, Jaap den, Hjorth, Lars, Kepak, Tomas, Kriviene, Izolda, Langer, Thorsten, Maeda, Miho, Márquez-Vega, Catalina, Michel, Gisela, Muraca, Monica, Najib, Mohamed, Nathan, Paul C., Panasiuk, Anna, Prasad, Maya, Roganovic, Jelena, Uyttebroeck, Anne, Winther, Jeanette F., Zadravec Zaletel, Lorna, van Dalen, Elvira C., van der Pal, Helena J. H., Hudson, Melissa M., and Kremer, Leontien C. M.
- Published
- 2022
- Full Text
- View/download PDF
5. Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study
- Author
-
van Atteveld, Jenneke E, de Winter, Demi T C, Pluimakers, Vincent G, Fiocco, Marta, Nievelstein, Rutger A J, Hobbelink, Monique G G, de Vries, Andrica C H, Loonen, Jacqueline J, van Dulmen-den Broeder, Eline, van der Pal, Helena J, Pluijm, Saskia M F, Kremer, Leontien C M, Ronckers, Cécile M, van der Heiden-van der Loo, Margriet, Versluijs, A Birgitta, Louwerens, Marloes, Bresters, Dorine, van Santen, Hanneke M, Olsson, Daniel S, Hoefer, Imo, van den Berg, Sjoerd A A, den Hartogh, Jaap, Tissing, Wim J E, Neggers, Sebastian J C M M, and van den Heuvel-Eibrink, Marry M
- Published
- 2023
- Full Text
- View/download PDF
6. Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study.
- Author
-
Bolier, Melissa, Pluimakers, Vincent G, Winter, Demi T C de, Fiocco, Marta, Berg, Sjoerd A A van den, Bresters, Dorine, Broeder, Eline van Dulmen-den, Loo, Margriet van der Heiden-van der, Höfer, Imo, Janssens, Geert O, Kremer, Leontien C M, Loonen, Jacqueline J, Louwerens, Marloes, Pal, Helena J van der, Pluijm, Saskia M F, Tissing, Wim J E, Santen, Hanneke M van, Vries, Andrica C H de, van der Lely, Aart-Jan, and Heuvel-Eibrink, Marry M van den
- Abstract
Objective Childhood cancer survivors (CCS) face an increased risk of early cardiovascular disease (CVD). In our nationwide CCS cohort, we assessed the prevalence and determinants of dyslipidemia, a well-established risk factor for accelerated atherosclerosis and CVD. Methods Prevalence of dyslipidemia was cross-sectionally assessed in 2338 adult CCS and compared to adults with no cancer history (Lifelines, n = 132 226). Dyslipidemia was defined by multiple classifications as well as lipid abnormalities to investigate the impact on prevalence and determinants. Logistic regression models, adjusted for age, sex, and BMI, were used to assess the cohort effect on presence of dyslipidemia. Determinants of dyslipidemia were identified through multivariable logistic regression. Results CCS (median age 34.7 year, median follow-up 27.1 year) had significantly increased odds of dyslipidemia compared to the reference cohort according to all classifications (NCEP-ATP-III, WHO, EGIR, CTCAEv.4.03). In survivors without lipid-lowering agents (n = 2007), lipid abnormalities were present in 20.6% (triglycerides > 1.7 mmol/L), 30.3% (HDL-c < 1.0/1.3 mmol/L (male/female)), 29.9% (total cholesterol > 5.2 mmol/L), 7.3% (LDL-c > 4.1 mmol/L), and 7.7% (apolipoprotein-B > 130 mg/dL). Compared to references without lipid-lowering agents (n = 126 631), survivors had increased odds of high triglycerides (aOR = 1.89, 95% CI = 1.68-2.13), low HDL-c (aOR = 2.73, 95% CI = 2.46-3.03), and high apolipoprotein-B (aOR = 1.84, 95% CI = 1.53-2.20). Sex, age, BMI, physical activity, abdominal/pelvic, cranial, and total body irradiation, alkylating agents, smoking, growth hormone deficiency, and diabetes mellitus were associated with (≥1 definition of) dyslipidemia in CCS. Conclusions CCS is at increased risk of dyslipidemia, with various modifiable and non-modifiable determinants identified, underscoring the importance of survivor-specific risk assessment tools to control cardiovascular morbidity and mortality in this high-risk population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Treatments affecting splenic function as a risk factor for valvular heart disease in Childhood Cancer Survivors: A DCCSS‐LATER study.
- Author
-
Houtman, Bente M., Walraven, Iris, Kapusta, Livia, Teske, Arco J., van Dulmen‐den Broeder, Eline, Tissing, Wim J. E., van den Heuvel‐Eibrink, Marry M., Versluys, A. B. Birgitta, Bresters, Dorine, van der Heiden‐van der Loo, Margriet, Ronckers, Cécile, Kok, Wouter E. M., van der Pal, Helena J. H., Pluijm, Saskia M. F., Janssens, Geert O., Blijlevens, Nicole M. A., Kremer, Leontien C. M., Loonen, Jacqueline J., and Feijen, E. A. M. Lieke
- Published
- 2024
- Full Text
- View/download PDF
8. Person-centred online lifestyle coaching in childhood, adolescent, and young adult cancer survivors: protocol of the multicentre PanCareFollowUp lifestyle intervention feasibility study
- Author
-
Bouwman, Eline, Hermens, Rosella P. M. G., Brown, Morven C., Araújo-Soares, Vera, Blijlevens, Nicole M. A., Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C. M., van den Oever, Selina R., van der Pal, Helena J. H., Skinner, Roderick, Pluijm, Saskia M. F., and Loonen, Jacqueline J.
- Published
- 2022
- Full Text
- View/download PDF
9. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
- Author
-
van Atteveld, Jenneke E, Mulder, Renée L, van den Heuvel-Eibrink, Marry M, Hudson, Melissa M, Kremer, Leontien C M, Skinner, Roderick, Wallace, W Hamish, Constine, Louis S, Higham, Claire E, Kaste, Sue C, Niinimäki, Riitta, Mostoufi-Moab, Sogol, Alos, Nathalie, Fintini, Danilo, Templeton, Kimberly J, Ward, Leanne M, Frey, Eva, Franceschi, Roberto, Pavasovic, Vesna, Karol, Seth E, Amin, Nadia L, Vrooman, Lynda M, Harila-Saari, Arja, Demoor-Goldschmidt, Charlotte, Murray, Robert D, Bardi, Edit, Lequin, Maarten H, Faienza, Maria Felicia, Zaikova, Olga, Berger, Claire, Mora, Stefano, Ness, Kirsten K, Neggers, Sebastian J C M M, Pluijm, Saskia M F, Simmons, Jill H, and Di Iorgi, Natascia
- Published
- 2021
- Full Text
- View/download PDF
10. Healthcare providers' expected barriers and facilitators to the implementation of person‐centered long‐term follow‐up care for childhood cancer survivors: A PanCareFollowUp study.
- Author
-
Breij, Dionne, Hjorth, Lars, Bouwman, Eline, Walraven, Iris, Kepak, Tomas, Kepakova, Katerina, Haupt, Riccardo, Muraca, Monica, Göttgens, Irene, Stollman, Iridi, Winther, Jeanette Falck, Kienesberger, Anita, Gsell, Hannah, Michel, Gisela, Blijlevens, Nicole, Pluijm, Saskia M. F., Roser, Katharina, Skinner, Roderick, Renard, Marleen, and Uyttebroeck, Anne
- Subjects
MEDICAL personnel ,CHILDHOOD cancer ,SOCIAL support ,CANCER survivors ,GENERAL practitioners - Abstract
Background: Childhood cancer survivors face high risks of adverse late health effects. Long‐term follow‐up care for childhood cancer survivors is crucial to improve their health and quality of life. However, implementation remains a challenge. To support implementation of high‐quality long‐term follow‐up care, we explored expected barriers and facilitators for establishing this follow‐up care among healthcare providers from four European clinics. Methods: A qualitative study was conducted using four focus groups comprising 30 healthcare providers in total. The semi‐structured interview guide was developed based on the Grol and Wensing framework. Data was analyzed following a thematic analysis, combining both inductive and deductive approaches to identify barriers and facilitators across the six levels of Grol and Wensing: innovation, professional, patient, social, organizational and economic and political. Results: Most barriers were identified on the organizational level, including insufficient staff, time, capacity and psychosocial support. Other main barriers included limited knowledge of late effects among healthcare providers outside the long‐term follow‐up care team, inability of some survivors to complete the survivor questionnaire and financial resources. Main facilitators included motivated healthcare providers and survivors, a skilled hospital team, collaborations with important stakeholders like general practitioners, and psychosocial care facilities, utilization of the international collaboration and reporting long‐term follow‐up care results to convince hospital managers. Conclusion: This study identified several factors for successful implementation of long‐term follow‐up care for childhood cancer survivors. Our findings showed that specific attention should be given to knowledge, capacity, and financial issues, along with addressing psychosocial issues of survivors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study.
- Author
-
Bouwman, Eline, Penson, Adriaan, de Valk, Maud, van den Oever, Selina R., van der Pal, Helena J. H., van Dulmen‐den Broeder, Eline, Blijlevens, Nicole M. A., Bresters, Dorine, Feijen, Elizabeth A. M., van den Heuvel‐Eibrink, Marry M., van der Heiden‐van der Loo, Margriet, Michel, Gisela, Ronckers, Cécile M., Teepen, Jop C., Tissing, Wim J. E., Versluys, Birgitta A. B., Kremer, Leontien C. M., Pluijm, Saskia M. F., and Loonen, Jacqueline J.
- Subjects
HEALTH behavior ,CHILDHOOD cancer ,CANCER survivors ,CHILDHOOD obesity ,UNHEALTHY lifestyles ,ADOLESCENT smoking - Abstract
Background: The objective of this study was to examine the prevalence of unhealthy lifestyle behaviors, overweight, and obesity in Dutch childhood cancer survivors (CCSs) compared with sibling controls and the Dutch general population. Other aims were to assess associated factors of unhealthy lifestyle behaviors, overweight, and obesity and to identify subgroups of CCSs at risk for these unhealthy statuses. Methods: The authors included 2253 CCSs and 906 siblings from the Dutch Childhood Cancer Survivor Study‐Late Effects After Childhood Cancer cohort, part 1, and added data from the Dutch general population. Questionnaire data were collected on overweight and obesity (body mass index >25.0 kg/m2), meeting physical activity guidelines (>150 minutes per week of moderate or vigorous exercises), excessive alcohol consumption (>14 and >21 alcoholic consumptions per week for women and men, respectively), daily smoking, and monthly drug use. Multivariable logistic regression analyses and two‐step cluster analyses were performed to examine sociodemographic‐related, health‐related, cancer‐related, and treatment‐related associated factors of unhealthy lifestyle behaviors and to identify subgroups of CCSs at risk for multiple unhealthy behaviors. Results: CCSs more often did not meet physical activity guidelines than their siblings (30.0% vs. 19.3%; p <.001). Married as marital status, lower education level, nonstudent status, and comorbidities were common associated factors for a body mass index ≥25.0 kg/m2 and insufficient physical activity, whereas male sex and lower education were shared associated factors for excessive alcohol consumption, daily smoking, and monthly drug use. A subgroup of CCSs was identified as excessive alcohol consumers, daily smokers, and monthly drug users. Conclusions: The current results emphasize the factors associated with unhealthy behaviors and the potential identification of CCSs who exhibit multiple unhealthy lifestyle behaviors. The results of this study indicate a higher prevalence of physical inactivity in childhood cancer survivors compared with sibling controls and the Dutch population, emphasizing the necessity for personalized health behavior interventions in childhood cancer survivors. These findings can be used in clinical practice to create awareness and to identify subgroups of childhood cancer survivors who need special attention regarding health behaviors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Treatments affecting splenic function as a risk factor for valvular heart disease in Childhood Cancer Survivors:A DCCSS-LATER study
- Author
-
Houtman, Bente M., Walraven, Iris, Kapusta, Livia, Teske, Arco J., van Dulmen-den Broeder, Eline, Tissing, Wim J. E., van den Heuvel-Eibrink, Marry M., Versluys, A. B. Birgitta, Bresters, Dorine, van der Heiden-vander Loo, Margriet, Ronckers, Cecile, Kok, Wouter E. M., van der Pal, Helena J. H., Pluijm, Saskia M. F., Janssens, Geert O., Blijlevens, Nicole M. A., Kremer, Leontien C. M., Loonen, Jacqueline J., Feijen, E. A. M. Lieke, Houtman, Bente M., Walraven, Iris, Kapusta, Livia, Teske, Arco J., van Dulmen-den Broeder, Eline, Tissing, Wim J. E., van den Heuvel-Eibrink, Marry M., Versluys, A. B. Birgitta, Bresters, Dorine, van der Heiden-vander Loo, Margriet, Ronckers, Cecile, Kok, Wouter E. M., van der Pal, Helena J. H., Pluijm, Saskia M. F., Janssens, Geert O., Blijlevens, Nicole M. A., Kremer, Leontien C. M., Loonen, Jacqueline J., and Feijen, E. A. M. Lieke
- Abstract
PurposeSplenectomy might be a risk factor for valvular heart disease (VHD) in adult Hodgkin lymphoma survivors. As this risk is still unclear for childhood cancer survivors (CCS), the aim of this study is to evaluate the association between treatments affecting splenic function (splenectomy and radiotherapy involving the spleen) and VHD in CCS.MethodsCCS were enrolled from the DCCSS-LATER cohort, consisting of 6,165 five-year CCS diagnosed between 1963 and 2002. Symptomatic VHD, defined as symptoms combined with a diagnostic test indicating VHD, was assessed from questionnaires and validated using medical records. Differences in the cumulative incidence of VHD between CCS who received treatments affecting splenic function and CCS who did not were assessed using the Gray test. Risk factors were analyzed in a multivariable Cox proportional hazards model.ResultsThe study population consisted of 5,286 CCS, with a median follow-up of 22 years (5-50 years), of whom 59 (1.1%) had a splenectomy and 489 (9.2%) radiotherapy involving the spleen. VHD was present in 21 CCS (0.4%). The cumulative incidence of VHD at the age of 40 years was significantly higher in CCS who received treatments affecting splenic function (2.7%, 95% confidence interval (CI) 0.4%-4.9%) compared with CCS without (0.4%, 95% CI 0.1%-0.7%) (Gray's test, p = 0.003). Splenectomy was significantly associated with VHD in a multivariable analysis (hazard ratio 8.6, 95% CI 3.1-24.1).Conclusions and implicationsSplenectomy was associated with VHD. Future research is needed to determine if CCS who had a splenectomy as part of cancer treatment might benefit from screening for VHD.
- Published
- 2024
13. Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio
- Author
-
Gosselt, Helen R., Verhoeven, Maxime M. A., de Rotte, Maurits C. F. J., Pluijm, Saskia M. F., Muller, Ittai B., Jansen, Gerrit, Tekstra, Janneke, Bulatović-Ćalasan, Maja, Heil, Sandra G., Lafeber, Floris P. J. G., Hazes, Johanna M. W., and de Jonge, Robert
- Published
- 2020
- Full Text
- View/download PDF
14. Methodology of the DCCSS later fatigue study: a model to investigate chronic fatigue in long-term survivors of childhood cancer
- Author
-
Penson, Adriaan, van Deuren, Sylvia, Bronkhorst, Ewald, Keizer, Ellen, Heskes, Tom, Coenen, Marieke J. H., Rosmalen, Judith G. M., Tissing, Wim J. E., van der Pal, Helena J. H., de Vries, Andrica C. H., van den Heuvel-Eibrink, Marry M., Neggers, Sebastian, Versluys, Birgitta A. B., Louwerens, Marloes, van der Heiden-van der Loo, Margriet, Pluijm, Saskia M. F., Grootenhuis, Martha, Blijlevens, Nicole, Kremer, Leontien C. M., van Dulmen-den Broeder, Eline, Knoop, Hans, and Loonen, Jacqueline
- Published
- 2021
- Full Text
- View/download PDF
15. Different subtypes of chronic fatigue in childhood cancer survivors: A DCCSS LATER study.
- Author
-
Penson, Adriaan, Walraven, Iris, Bronkhorst, Ewald, Grootenhuis, Martha A., Maurice‐Stam, Heleen, Loo, Margriet van der Heiden‐van der, Tissing, Wim J. E., van der Pal, Helena J. H., de Vries, Andrica C. H., Bresters, Dorine, Ronckers, Cécile M., van den Heuvel‐Eibrink, Marry M., Neggers, Sebastian, Versluys, Birgitta A. B., Louwerens, Marloes, Pluijm, Saskia M. F., Blijlevens, Nicole, van Dulmen‐den Broeder, Eline, Kremer, Leontien C. M., and Knoop, Hans
- Published
- 2024
- Full Text
- View/download PDF
16. Physical frailty deteriorates after a 5‐day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study
- Author
-
Verwaaijen, Emma J., primary, van Hulst, Annelienke M., additional, Hartman, Annelies, additional, Pieters, Rob, additional, Fiocco, Marta, additional, Pluijm, Saskia M. F., additional, van Litsenburg, Raphaële R. L., additional, Grootenhuis, Martha A., additional, van den Akker, Erica L. T., additional, and van den Heuvel‐Eibrink, Marry M., additional
- Published
- 2023
- Full Text
- View/download PDF
17. Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER):a cross-sectional study
- Author
-
van Atteveld, Jenneke E, de Winter, Demi T C, Pluimakers, Vincent G, Fiocco, Marta, Nievelstein, Rutger A J, Hobbelink, Monique G G, Kremer, Leontien C M, Grootenhuis, Martha A, Maurice-Stam, Heleen, Tissing, Wim J E, de Vries, Andrica C H, Loonen, Jacqueline J, van Dulmen-den Broeder, Eline, van der Pal, Helena J H, Pluijm, Saskia M F, van der Heiden-van der Loo, Margriet, Versluijs, A Birgitta, Louwerens, Marloes, Bresters, Dorine, van Santen, Hanneke M, Hoefer, Imo, van den Berg, Sjoerd A A, den Hartogh, Jaap, Hoeijmakers, Jan H J, Neggers, Sebastian J C M M, van den Heuvel-Eibrink, Marry M, van Atteveld, Jenneke E, de Winter, Demi T C, Pluimakers, Vincent G, Fiocco, Marta, Nievelstein, Rutger A J, Hobbelink, Monique G G, Kremer, Leontien C M, Grootenhuis, Martha A, Maurice-Stam, Heleen, Tissing, Wim J E, de Vries, Andrica C H, Loonen, Jacqueline J, van Dulmen-den Broeder, Eline, van der Pal, Helena J H, Pluijm, Saskia M F, van der Heiden-van der Loo, Margriet, Versluijs, A Birgitta, Louwerens, Marloes, Bresters, Dorine, van Santen, Hanneke M, Hoefer, Imo, van den Berg, Sjoerd A A, den Hartogh, Jaap, Hoeijmakers, Jan H J, Neggers, Sebastian J C M M, and van den Heuvel-Eibrink, Marry M
- Abstract
BACKGROUND: Childhood cancer survivors appear to be at increased risk of frailty and sarcopenia, but evidence on the occurrence of and high-risk groups for these aging phenotypes is scarce, especially in European survivors. The aim of this cross-sectional study was to assess the prevalence of and explore risk factors for pre-frailty, frailty, and sarcopenia in a national cohort of Dutch childhood cancer survivors diagnosed between 1963 and 2001.METHODS: Eligible individuals (alive at the time of study, living in the Netherlands, age 18-45 years, and had not previously declined to participate in a late-effects study) from the Dutch Childhood Cancer Survivor Study (DCCSS-LATER) cohort were invited to take part in this cross-sectional study. We defined pre-frailty and frailty according to modified Fried criteria, and sarcopenia according to the European Working Group on Sarcopenia in Older People 2 definition. Associations between these conditions and demographic and treatment-related as well as endocrine and lifestyle-related factors were estimated with two separate multivariable logistic regression models in survivors with any frailty measurement or complete sarcopenia measurements.FINDINGS: 3996 adult survivors of the DCCSS-LATER cohort were invited to participate in this cross-sectional study. 1993 non-participants were excluded due to lack of response or a decline to participate and 2003 (50·1%) childhood cancer survivors aged 18-45 years were included. 1114 (55·6%) participants had complete frailty measurements and 1472 (73·5%) participants had complete sarcopenia measurements. Mean age at participation was 33·1 years (SD 7·2). 1037 (51·8%) participants were male, 966 (48·2%) were female, and none were transgender. In survivors with complete frailty measurements or complete sarcopenia measurements, the percentage of pre-frailty was 20·3% (95% CI 18·0-22·7), frailty was 7·4% (6·0-9·0), and sarcopenia was 4·4% (3·5-5·6). In the models for pre-frai
- Published
- 2023
18. Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study.
- Author
-
Pluimakers, Vincent G., van Atteveld, Jenneke E., de Winter, Demi T. C., Bolier, Melissa, Fiocco, Marta, Nievelstein, Rutger Jan A. J., Janssens, Geert O. R., Bresters, Dorine, van der Heiden-van der Loo, Margriet, de Vries, Andrica C. H., Louwerens, Marloes, van der Pal, Heleen J., Pluijm, Saskia M. F., Ronckers, Cecile M., Versluijs, Andrica B., Kremer, Leontien C. M., Loonen, Jacqueline J., van Dulmen-den Broeder, Eline, Tissing, Wim J. E., and van Santen, Hanneke M.
- Subjects
DISEASE risk factors ,OVERWEIGHT persons ,OBESITY ,CHILDHOOD cancer ,CANCER survivors - Abstract
Background: Overweight and obesity are common challenges among childhood cancer survivors. Overweight may be disguised, as survivors can have normal weight but high fat percentage (fat%) on dual-energy X-ray absorptiometry (DXA). We aimed to assess prevalence, identify determinants and biomarkers, and assess which method captures overweight best, in a nationwide cohort. Methods: The prevalence of overweight and obesity, primarily defined by body mass index (BMI), was assessed in the DCCSS-LATER cohort of adult survivors treated from 1963-2002, with the LifeLines cohort as reference. The associations between risk factors and overweight metrics were investigated using logistic regression. Additional overweight metrics included DXA fat%, waist circumference (WC), waist/hip ratio (WHR), waist/height ratio (WHtR), and high-molecular-weight (HMW) adiponectin. Results: A total of 2338 (mean age 35.5 years, follow-up 28.3 years) survivors participated. The overweight prevalence was 46.3% in men and 44.3% in women (obesity 11.2% and 15.9%, morbid obesity 2.4% and 5.4%), with highest rates among brain tumor survivors. Compared to controls, there was no overall increased overweight rate, but this was higher in women > 50 years, morbid obesity in men > 50 years. Overweight at cancer diagnosis (adjusted odds ratio [aOR] = 3.83, 95% CI 2.19-6.69), cranial radiotherapy (aOR = 3.21, 95% CI 1.99-5.18), and growth hormone deficiency (separate model, aOR = 1.61, 95% CI 1.00-2.59) were associated with overweight. Using BMI, WC, WHR, and WHtR, overweight prevalence was similar. Low HMW adiponectin, present in only 4.5% of survivors, was an insensitive overweight marker. Dual-energy X-ray absorptiometry–based classification identified overweight in an additional 30%, particularly after abdominal radiotherapy, total body irradiation, anthracyclines, and platinum. Conclusions: Overweight occurs in almost half of long-term survivors. There was no overall increased incidence of overweight compared to controls. We identified factors associated with overweight, as well as subgroups of survivors in whom DXA can more reliably assess overweight. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER): a cross-sectional study
- Author
-
van Atteveld, Jenneke E, primary, de Winter, Demi T C, additional, Pluimakers, Vincent G, additional, Fiocco, Marta, additional, Nievelstein, Rutger A J, additional, Hobbelink, Monique G G, additional, Kremer, Leontien C M, additional, Grootenhuis, Martha A, additional, Maurice-Stam, Heleen, additional, Tissing, Wim J E, additional, de Vries, Andrica C H, additional, Loonen, Jacqueline J, additional, van Dulmen-den Broeder, Eline, additional, van der Pal, Helena J H, additional, Pluijm, Saskia M F, additional, van der Heiden-van der Loo, Margriet, additional, Versluijs, A Birgitta, additional, Louwerens, Marloes, additional, Bresters, Dorine, additional, van Santen, Hanneke M, additional, Hoefer, Imo, additional, van den Berg, Sjoerd A A, additional, den Hartogh, Jaap, additional, Hoeijmakers, Jan H J, additional, Neggers, Sebastian J C M M, additional, and van den Heuvel-Eibrink, Marry M, additional
- Published
- 2023
- Full Text
- View/download PDF
20. Additional file 2 of Person-centred online lifestyle coaching in childhood, adolescent, and young adult cancer survivors: protocol of the multicentre PanCareFollowUp lifestyle intervention feasibility study
- Author
-
Bouwman, Eline, Hermens, Rosella P. M. G., Brown, Morven C., Araújo-Soares, Vera, Blijlevens, Nicole M. A., Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C. M., van den Oever, Selina R., van der Pal, Helena J. H., Skinner, Roderick, Pluijm, Saskia M. F., and Loonen, Jacqueline J.
- Abstract
Additional file 2. The TIDieR (Template for Intervention Description and Replication) Checklist.
- Published
- 2023
- Full Text
- View/download PDF
21. Additional file 1 of Person-centred online lifestyle coaching in childhood, adolescent, and young adult cancer survivors: protocol of the multicentre PanCareFollowUp lifestyle intervention feasibility study
- Author
-
Bouwman, Eline, Hermens, Rosella P. M. G., Brown, Morven C., Araújo-Soares, Vera, Blijlevens, Nicole M. A., Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C. M., van den Oever, Selina R., van der Pal, Helena J. H., Skinner, Roderick, Pluijm, Saskia M. F., and Loonen, Jacqueline J.
- Abstract
Additional file 1. SPIRIT 2013 Checklist.
- Published
- 2023
- Full Text
- View/download PDF
22. Additional file 3 of Person-centred online lifestyle coaching in childhood, adolescent, and young adult cancer survivors: protocol of the multicentre PanCareFollowUp lifestyle intervention feasibility study
- Author
-
Bouwman, Eline, Hermens, Rosella P. M. G., Brown, Morven C., Araújo-Soares, Vera, Blijlevens, Nicole M. A., Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C. M., van den Oever, Selina R., van der Pal, Helena J. H., Skinner, Roderick, Pluijm, Saskia M. F., and Loonen, Jacqueline J.
- Abstract
Additional file 3. Behavioural Change Techniques and their presumed Mechanisms of Action.
- Published
- 2023
- Full Text
- View/download PDF
23. Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol
- Author
-
van Kalsbeek, Rebecca J, primary, Korevaar, Joke C, additional, Rijken, Mieke, additional, Haupt, Riccardo, additional, Muraca, Monica, additional, Kepák, Tomáš, additional, Kepakova, Katerina, additional, Blondeel, Anne, additional, Boes, Stefan, additional, Frederiksen, Line E, additional, Essiaf, Samira, additional, Winther, Jeanette F, additional, Hermens, Rosella P M G, additional, Kienesberger, Anita, additional, Loonen, Jacqueline J, additional, Michel, Gisela, additional, Mulder, Renée L, additional, O'Brien, Kylie B, additional, van der Pal, Helena J H, additional, Pluijm, Saskia M F, additional, Roser, Katharina, additional, Skinner, Roderick, additional, Renard, Marleen, additional, Uyttebroeck, Anne, additional, Follin, Cecilia, additional, Hjorth, Lars, additional, and Kremer, Leontien C M, additional
- Published
- 2022
- Full Text
- View/download PDF
24. Healthcare professionals' perceived barriers and facilitators of health behavior support provision: A qualitative study
- Author
-
Bouwman, Eline, Pluijm, Saskia M. F., Stollman, Iridi, Araujo‐Soares, Vera, Blijlevens, Nicole M. A., Follin, Cecilia, Falck Winther, Jeanette, Hjorth, Lars, Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C. M., Muraca, Monica, van der Pal, Helena J. H., Schneider, Carina, Uyttebroeck, Anne, Vercruysse, Gertrui, Skinner, Roderick, Brown, Morven C., Hermens, Rosella P. M. G., Loonen, Jacqueline J., Paediatric Oncology, Paediatric Pulmonology, CCA - Cancer Treatment and Quality of Life, and AR&D - Amsterdam Reproduction & Development
- Subjects
Cancer Research ,All institutes and research themes of the Radboud University Medical Center ,Oncology ,screening ,clinical management ,Radiology, Nuclear Medicine and imaging ,survival ,Women's cancers Radboud Institute for Health Sciences [Radboudumc 17] ,Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] ,Rare cancers Radboud Institute for Health Sciences [Radboudumc 9] ,pediatric cancer - Abstract
Contains fulltext : 291775.pdf (Publisher’s version ) (Open Access) BACKGROUND: Childhood cancer survivors (CCSs) have an increased risk of developing chronic health conditions. Evidence suggests that poor health behaviors further increase health risks. Healthcare professionals (HCPs) involved in survivorship care have a key role in providing health behavior support (HBS) but can feel limited in their ability to do so. This study aims to explore European HCPs perceived facilitators and barriers to providing HBS to CCSs. METHODS: Five focus groups with 30 HCPs from survivorship care clinics across Europe were conducted. Topic guides were informed by the Theoretical Domains Framework (TDF) to capture domains that may influence provision of HBS. Focus groups were analyzed with thematic analysis. Transcripts were inductively coded, after which axial coding was applied to organize codes into categories. Finally, categories were mapped onto the TDF domains. RESULTS: Nine TDF domains were identified in the data. The most commonly reported TDF domains were "Knowledge", "Skills", and "Environmental context and resources". HCPs indicated that their lack of knowledge of the association between late effects and health behaviors, besides time restrictions, were barriers to HBS. Facilitators for HBS included possession of skills needed to pass on health behavior information, good clinic organization, and an established network of HCPs. CONCLUSIONS: This study identified education and training of HCPs as key opportunities to improve HBS. Survivorship care clinics should work towards establishing well-integrated structured care with internal and external networks including HBS being part of routine care. Proper understanding of facilitators and barriers should lead to better survivorship care for CCSs.
- Published
- 2022
- Full Text
- View/download PDF
25. Genetic Biomarkers to Identify the Risk of Osteonecrosis in Children with Acute Lymphoblastic Leukemia
- Author
-
den Hoed, Marissa A. H., Pluijm, Saskia M. F., Uitterlinden, André G., Pieters, Rob, and van den Heuvel-Eibrink, Marry M.
- Published
- 2016
- Full Text
- View/download PDF
26. Perceived barriers and facilitators to health behaviors in European childhood cancer survivors: A qualitative PanCareFollowUp study.
- Author
-
Bouwman, Eline, Pluijm, Saskia M. F., Stollman, Iridi, Araujo‐Soares, Vera, Blijlevens, Nicole M. A., Follin, Cecilia, Winther, Jeanette F., Hjorth, Lars, Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C. M., Muraca, Monica, van der Pal, Helena J. H., Schneider, Carina, Uyttebroeck, Anne, Vercruysse, Gertrui, Skinner, Rod, Brown, Morven C., Hermens, Rosella P. M. G., and Loonen, Jacqueline J.
- Subjects
- *
HEALTH behavior , *CHILDHOOD cancer , *CANCER survivors , *MEDICAL personnel , *SOCIAL influence , *ALCOHOL drinking - Abstract
Background: Healthy behaviors, that is, engaging in regular physical activities, maintaining a healthy diet, limiting alcohol consumption, and avoiding tobacco and drug use, decrease the risk of developing late adverse health conditions in childhood cancer survivors. However, childhood cancer survivors may experience barriers to adopting and maintaining healthy behaviors. This study aimed to assess these barriers and facilitators to health behavior adoption and maintenance in childhood cancer survivors. Methods: A focus group (n = 12) and semi‐structured telephone interviews (n = 20) were conducted with a selected sample of European and Dutch childhood cancer survivors, respectively. The Theoretical Domains Framework (TDF) was used to inform the topic guide and analysis. Inductive thematic analysis was applied to identify categories relating to barriers and facilitators of health behavior adoption and maintenance, after which they were deductively mapped onto the TDF. Results: Ten TDF domains were identified in the data of which "Knowledge," "Beliefs about consequences," "Environmental context and resources," and "Social influences" were most commonly reported. Childhood cancer survivors expressed a need for knowledge on the importance of healthy behaviors, possibly provided by healthcare professionals. They indicated physical and long‐term benefits of healthy behaviors, available professional support, and a supporting and health‐consciously minded work and social environment to be facilitators. Barriers were mostly related to a lack of available time and an unhealthy environment. Lastly, (social) media was perceived as both a barrier and a facilitator to healthy behaviors. Conclusion: This study has identified education and available professional support in health behaviors and the relevance of healthy behaviors for childhood cancer survivors as key opportunities for stimulating health behavior adoption in childhood cancer survivors. Incorporating health behavior support and interventions for this population should therefore be a high priority. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. The Impact of Cancer-Related Fatigue on HRQOL in Survivors of Childhood Cancer: A DCCSS LATER Study
- Author
-
Penson, Adriaan, primary, Walraven, Iris, additional, Bronkhorst, Ewald, additional, Maurice-Stam, Heleen, additional, Grootenhuis, Martha A., additional, Van der Heiden-van der Loo, Margriet, additional, Tissing, Wim J. E., additional, Van der Pal, Helena J. H., additional, De Vries, Andrica C. H., additional, Bresters, Dorine, additional, Ronckers, Cécile, additional, Van den Heuvel, Marry M., additional, Neggers, Sebastian J. C. M. M., additional, Versluys, Birgitta A. B., additional, Louwerens, Marloes, additional, Pluijm, Saskia M. F., additional, Kremer, Leontien C. M., additional, Blijlevens, Nicole, additional, Van Dulmen-den Broeder, Eline, additional, Knoop, Hans, additional, and Loonen, Jacqueline, additional
- Published
- 2022
- Full Text
- View/download PDF
28. Shrunken pore syndrome in childhood cancer survivors treated with potentially nephrotoxic therapy
- Author
-
Kooijmans, Esmee C. M., van der Pal, Helena J. H., Pilon, Maxime C. F., Pluijm, Saskia M. F., van der van der Loo, Margriet, Kremer, Leontien C. M., Bresters, Dorine, van Dulmen-den Broeder, Eline, van den Heuvel-eibrink, Marry M., Loonen, Jacqueline J., Louwerens, Marloes, Neggers, Sebastian J. C., van Santen, Hanneke M., Tissing, Wim J. E., de Vries, Andrica C. H., Kaspers, Gertjan J. L., Veening, Margreet A., Bokenkamp, Arend, Kooijmans, Esmee C. M., van der Pal, Helena J. H., Pilon, Maxime C. F., Pluijm, Saskia M. F., van der van der Loo, Margriet, Kremer, Leontien C. M., Bresters, Dorine, van Dulmen-den Broeder, Eline, van den Heuvel-eibrink, Marry M., Loonen, Jacqueline J., Louwerens, Marloes, Neggers, Sebastian J. C., van Santen, Hanneke M., Tissing, Wim J. E., de Vries, Andrica C. H., Kaspers, Gertjan J. L., Veening, Margreet A., and Bokenkamp, Arend
- Abstract
Childhood cancer survivors (CCS) are at risk of kidney dysfunction. Recently, the shrunken pore syndrome (SPS) has been described, which is characterized by selectively impaired filtration of larger molecules like cystatin C, while filtration of smaller molecules like creatinine is unaltered. It has been associated with increased mortality, even in the presence of a normal estimated glomerular filtration rate (eGFR). The aim of this study was to evaluate the prevalence of SPS in CCS exposed to potentially nephrotoxic therapy. In the Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 Renal study, a nationwide cross-sectional cohort study, 1024 CCS ≥5 years after diagnosis, aged ≥18 years at study, treated between 1963-2001 with nephrectomy, abdominal radiotherapy, total body irradiation, cisplatin, carboplatin, ifosfamide, high-dose cyclophosphamide or hematopoietic stem cell transplantation participated, and 500 age- and sex-matched controls form Lifelines. SPS was defined as an eGFR cys/eGFR cr ratio <0.6 in the absence of non-GFR determinants of cystatin C and creatinine metabolism (i.e. hyperthyroidism, corticosteroids, underweight). Three pairs of eGFR-equations were used; CKD-EPI cys/CKD-EPI cr, CAPA/LMR, and FAS cys/FAS age. Median age was 32 years. Although an eGFR cys/eGFR cr ratio <0.6 was more common in CCS (1.0%) than controls (0%) based on the CKD-EPI equations, most cases were explained by non-GFR determinants. The prevalence of SPS in CCS was 0.3% (CKD-EPI equations), 0.2% (CAPA/LMR) and 0.1% (FAS equations), and not increased compared to controls. CCS treated with nephrotoxic therapy are not at increased risk for SPS compared to controls. Yet, non-GFR determinants are more common and should be taken into account when estimating GFR.
- Published
- 2022
29. Evaluating the feasibility, effectiveness and costs of implementing person-centred follow-up care for childhood cancer survivors in four European countries: the PanCareFollowUp Care prospective cohort study protocol
- Author
-
Von Kalsbeek, Rebecca J., Korevaar, Joke C., Rijken, Mieke, Haupt, Riccardo, Muraca, Monica, Kepák, Tomáš, Kepakova, Katerina, Blondeel, Anne, Boes, Stefan, Frederiksen, Line E, Essiaf, Samira, Winther, Jeanette F, Hermens, Rosella P M G, Kienesberger, Anita, Loonen, Jacqueline J, Michel, Gisela, Mulder, Renée L, O'Brien, Kylie B, van der Pal, Helena J H, Pluijm, Saskia M F, Roser, Katharina, Skinner, Roderick, Renard, Marleen, Uyttebroeck, Anne, Follin, Cecilia, Hjorth, Lars, Kremer, Leontien C M, Von Kalsbeek, Rebecca J., Korevaar, Joke C., Rijken, Mieke, Haupt, Riccardo, Muraca, Monica, Kepák, Tomáš, Kepakova, Katerina, Blondeel, Anne, Boes, Stefan, Frederiksen, Line E, Essiaf, Samira, Winther, Jeanette F, Hermens, Rosella P M G, Kienesberger, Anita, Loonen, Jacqueline J, Michel, Gisela, Mulder, Renée L, O'Brien, Kylie B, van der Pal, Helena J H, Pluijm, Saskia M F, Roser, Katharina, Skinner, Roderick, Renard, Marleen, Uyttebroeck, Anne, Follin, Cecilia, Hjorth, Lars, and Kremer, Leontien C M
- Abstract
Introduction: Long-term survival after childhood cancer often comes at the expense of late, adverse health conditions. However, survivorship care is frequently not available for adult survivors in Europe. The PanCareFollowUp Consortium therefore developed the PanCareFollowUp Care Intervention, an innovative person-centred survivorship care model based on experiences in the Netherlands. This paper describes the protocol of the prospective cohort study (Care Study) to evaluate the feasibility and the health economic, clinical and patient-reported outcomes of implementing PanCareFollowUp Care as usual care in four European countries.Methods and analysis In this prospective, longitudinal cohort study with at least 6 months of follow-up, 800 childhood cancer survivors will receive the PanCareFollowUp Care Intervention across four study sites in Belgium, Czech Republic, Italy and Sweden, representing different healthcare systems. The PanCareFollowUp Care Intervention will be evaluated according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework. Clinical and research data are collected through questionnaires, a clinic visit for multiple medical assessments and a follow-up call. The primary outcome is empowerment, assessed with the Health Education Impact Questionnaire. A central data centre will perform quality checks, data cleaning and data validation, and provide support in data analysis. Multilevel models will be used for repeated outcome measures, with subgroup analysis, for example, by study site, attained age, sex or diagnosis.Ethics and dissemination This study will be conducted in accordance with the guidelines of Good Clinical Practice and the Declaration of Helsinki. The study protocol has been reviewed and approved by all relevant ethics committees. The evidence and insights gained by this study will be summarised in a Replication Manual, also including the tools required to implement the PanCareFollowUp Care Interve, + ID der Publikation: unilu_61784 + Sprache: Englisch + Letzte Aktualisierung: 2022-11-30 17:16:31
- Published
- 2022
30. Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire--a DCCSS LATER study
- Author
-
PMC Medisch specialisten, Speerpunt, Zorg en O&O, Child Health, PMC Research, Penson, Adriaan, Walraven, Iris, Bronkhorst, Ewald, Grootenhuis, Martha A, Tissing, Wim J E, van der Pal, Helena J H, de Vries, Andrica C H, van den Heuvel-Eibrink, Marry M, Neggers, Sebastian, Versluys, Birgitta A B, Louwerens, Marloes, Pluijm, Saskia M F, Blijlevens, Nicole, van der Heiden-van der Loo, Margriet, Kremer, Leontien C M, van Dulmen-den Broeder, Eline, Knoop, Hans, Loonen, Jacqueline, PMC Medisch specialisten, Speerpunt, Zorg en O&O, Child Health, PMC Research, Penson, Adriaan, Walraven, Iris, Bronkhorst, Ewald, Grootenhuis, Martha A, Tissing, Wim J E, van der Pal, Helena J H, de Vries, Andrica C H, van den Heuvel-Eibrink, Marry M, Neggers, Sebastian, Versluys, Birgitta A B, Louwerens, Marloes, Pluijm, Saskia M F, Blijlevens, Nicole, van der Heiden-van der Loo, Margriet, Kremer, Leontien C M, van Dulmen-den Broeder, Eline, Knoop, Hans, and Loonen, Jacqueline
- Published
- 2022
31. Healthcare professionals' perceived barriers and facilitators of health behavior support provision: A qualitative study.
- Author
-
Bouwman, Eline, Pluijm, Saskia M. F., Stollman, Iridi, Araujo‐Soares, Vera, Blijlevens, Nicole M. A., Follin, Cecilia, Falck Winther, Jeanette, Hjorth, Lars, Kepak, Tomas, Kepakova, Katerina, Kremer, Leontien C. M., Muraca, Monica, van der Pal, Helena J. H., Schneider, Carina, Uyttebroeck, Anne, Vercruysse, Gertrui, Skinner, Roderick, Brown, Morven C., Hermens, Rosella P. M. G., and Loonen, Jacqueline J.
- Subjects
HEALTH behavior ,MEDICAL personnel ,INFORMATION-seeking behavior ,QUALITATIVE research ,THEMATIC analysis - Abstract
Background: Childhood cancer survivors (CCSs) have an increased risk of developing chronic health conditions. Evidence suggests that poor health behaviors further increase health risks. Healthcare professionals (HCPs) involved in survivorship care have a key role in providing health behavior support (HBS) but can feel limited in their ability to do so. This study aims to explore European HCPs perceived facilitators and barriers to providing HBS to CCSs. Methods: Five focus groups with 30 HCPs from survivorship care clinics across Europe were conducted. Topic guides were informed by the Theoretical Domains Framework (TDF) to capture domains that may influence provision of HBS. Focus groups were analyzed with thematic analysis. Transcripts were inductively coded, after which axial coding was applied to organize codes into categories. Finally, categories were mapped onto the TDF domains. Results: Nine TDF domains were identified in the data. The most commonly reported TDF domains were "Knowledge", "Skills", and "Environmental context and resources". HCPs indicated that their lack of knowledge of the association between late effects and health behaviors, besides time restrictions, were barriers to HBS. Facilitators for HBS included possession of skills needed to pass on health behavior information, good clinic organization, and an established network of HCPs. Conclusions: This study identified education and training of HCPs as key opportunities to improve HBS. Survivorship care clinics should work towards establishing well‐integrated structured care with internal and external networks including HBS being part of routine care. Proper understanding of facilitators and barriers should lead to better survivorship care for CCSs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire––a DCCSS LATER study
- Author
-
Penson, Adriaan, primary, Walraven, Iris, additional, Bronkhorst, Ewald, additional, Grootenhuis, Martha A., additional, Tissing, Wim J. E., additional, van der Pal, Helena J. H., additional, de Vries, Andrica C. H., additional, van den Heuvel‐Eibrink, Marry M., additional, Neggers, Sebastian, additional, Versluys, Birgitta A. B., additional, Louwerens, Marloes, additional, Pluijm, Saskia M. F., additional, Blijlevens, Nicole, additional, van der Heiden‐van der Loo, Margriet, additional, Kremer, Leontien C. M., additional, van Dulmen‐den Broeder, Eline, additional, Knoop, Hans, additional, and Loonen, Jacqueline, additional
- Published
- 2021
- Full Text
- View/download PDF
33. Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis
- Author
-
de Rotte, Maurits C F J, den Boer, Ethan, de Jong, Pascal H P, Pluijm, Saskia M F, Ćalasan, Maja Bulatović, Weel, Angelique E, Huisman, Margriet A, Gerards, Andreas H, van Schaeybroeck, Barbara, Wulffraat, Nico M, Lindemans, Jan, Hazes, Johanna M W, and de Jonge, Robert
- Published
- 2015
- Full Text
- View/download PDF
34. Additional file 1 of Methodology of the DCCSS later fatigue study: a model to investigate chronic fatigue in long-term survivors of childhood cancer
- Author
-
Penson, Adriaan, Van Deuren, Sylvia, Bronkhorst, Ewald, Keizer, Ellen, Heskes, Tom, Coenen, Marieke J. H., Rosmalen, Judith G. M., Tissing, Wim J. E., Van Der Pal, Helena J. H., Andrica C. H. De Vries, Van Den Heuvel-Eibrink, Marry M., Neggers, Sebastian, Versluys, Birgitta A. B., Louwerens, Marloes, Van Der Heiden-Van Der Loo, Margriet, Pluijm, Saskia M. F., Grootenhuis, Martha, Blijlevens, Nicole, Kremer, Leontien C. M., Van Dulmen-Den Broeder, Eline, Knoop, Hans, and Loonen, Jacqueline
- Abstract
Additional file 1: Figure S1. Flowchart of the categorization process of survivors who received Radiotherapy. Table S1. Items in the questionnaires regarding the participant’s demographic data, medical history and current medical state. Table S2. Model parameters and how they were measured in the DCCSS LATER fatigue study.
- Published
- 2021
- Full Text
- View/download PDF
35. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors : evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
- Author
-
van Atteveld, Jenneke E., Mulder, Renee L., van den Heuvel-Eibrink, Marry M., Hudson, Melissa M., Kremer, Leontien C. M., Skinner, Roderick, Wallace, W. Hamish, Constine, Louis S., Higham, Claire E., Kaste, Sue C., Niinimaki, Riitta, Mostoufi-Moab, Sogol, Alos, Nathalie, Fintini, Danilo, Templeton, Kimberly J., Ward, Leanne M., Frey, Eva, Franceschi, Roberto, Pavasovic, Vesna, Karol, Seth E., Amin, Nadia L., Vrooman, Lynda M., Harila-Saari, Arja H., Demoor-Goldschmidt, Charlotte, Murray, Robert D., Bardi, Edit, Lequin, Maarten H., Faienza, Maria Felicia, Zaikova, Olga, Berger, Claire, Mora, Stefano, Ness, Kirsten K., Neggers, Sebastian J. C. M. M., Pluijm, Saskia M. F., Simmons, Jill H., Di Iorgi, Natascia, van Atteveld, Jenneke E., Mulder, Renee L., van den Heuvel-Eibrink, Marry M., Hudson, Melissa M., Kremer, Leontien C. M., Skinner, Roderick, Wallace, W. Hamish, Constine, Louis S., Higham, Claire E., Kaste, Sue C., Niinimaki, Riitta, Mostoufi-Moab, Sogol, Alos, Nathalie, Fintini, Danilo, Templeton, Kimberly J., Ward, Leanne M., Frey, Eva, Franceschi, Roberto, Pavasovic, Vesna, Karol, Seth E., Amin, Nadia L., Vrooman, Lynda M., Harila-Saari, Arja H., Demoor-Goldschmidt, Charlotte, Murray, Robert D., Bardi, Edit, Lequin, Maarten H., Faienza, Maria Felicia, Zaikova, Olga, Berger, Claire, Mora, Stefano, Ness, Kirsten K., Neggers, Sebastian J. C. M. M., Pluijm, Saskia M. F., Simmons, Jill H., and Di Iorgi, Natascia
- Abstract
Childhood, adolescent, and young adult cancer survivors are at increased risk of reduced bone mineral density. Clinical practice surveillance guidelines are important for timely diagnosis and treatment of these survivors, which could improve bone mineral density parameters and prevent fragility fractures. Discordances across current late effects guidelines necessitated international harmonisation of recommendations for bone mineral density surveillance. The International Late Effects of Childhood Cancer Guideline Harmonization Group therefore established a panel of 36 experts from ten countries, representing a range of relevant medical specialties. The evidence of risk factors for very low and low bone mineral density and fractures, surveillance modality, timing of bone mineral density surveillance, and treatment of very low and low bone mineral density were evaluated and critically appraised, and harmonised recommendations for childhood, adolescent, and young adult cancer survivors were formulated. We graded the recommendations based on the quality of evidence and balance between potential benefits and harms. Bone mineral density surveillance is recommended for survivors treated with cranial or craniospinal radiotherapy and is reasonable for survivors treated with total body irradiation. Due to insufficient evidence, no recommendation can be formulated for or against bone mineral density surveillance for survivors treated with corticosteroids. This surveillance decision should be made by the survivor and health-care provider together, after careful consideration of the potential harms and benefits and additional risk factors. We recommend to carry out bone mineral density surveillance using dualenergy x-ray absorptiometry at entry into long-term follow-up, and if normal (Z-score > -1), repeat when the survivor is aged 25 years. Between these measurements and thereafter, surveillance should be done as clinically indicated. These recommendations facilitate evidenc
- Published
- 2021
- Full Text
- View/download PDF
36. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
- Author
-
MS Radiologie, Circulatory Health, van Atteveld, Jenneke E., Mulder, Renee L., van den Heuvel-Eibrink, Marry M., Hudson, Melissa M., Kremer, Leontien C. M., Skinner, Roderick, Wallace, W. Hamish, Constine, Louis S., Higham, Claire E., Kaste, Sue C., Niinimaki, Riitta, Mostoufi-Moab, Sogol, Alos, Nathalie, Fintini, Danilo, Templeton, Kimberly J., Ward, Leanne M., Frey, Eva, Franceschi, Roberto, Pavasovic, Vesna, Karol, Seth E., Amin, Nadia L., Vrooman, Lynda M., Harila-Saari, Arja, Demoor-Goldschmidt, Charlotte, Murray, Robert D., Bardi, Edit, Lequin, Maarten H., Faienza, Maria Felicia, Zaikova, Olga, Berger, Claire, Mora, Stefano, Ness, Kirsten K., Neggers, Sebastian J. C. M. M., Pluijm, Saskia M. F., Simmons, Jill H., Di Iorgi, Natascia, MS Radiologie, Circulatory Health, van Atteveld, Jenneke E., Mulder, Renee L., van den Heuvel-Eibrink, Marry M., Hudson, Melissa M., Kremer, Leontien C. M., Skinner, Roderick, Wallace, W. Hamish, Constine, Louis S., Higham, Claire E., Kaste, Sue C., Niinimaki, Riitta, Mostoufi-Moab, Sogol, Alos, Nathalie, Fintini, Danilo, Templeton, Kimberly J., Ward, Leanne M., Frey, Eva, Franceschi, Roberto, Pavasovic, Vesna, Karol, Seth E., Amin, Nadia L., Vrooman, Lynda M., Harila-Saari, Arja, Demoor-Goldschmidt, Charlotte, Murray, Robert D., Bardi, Edit, Lequin, Maarten H., Faienza, Maria Felicia, Zaikova, Olga, Berger, Claire, Mora, Stefano, Ness, Kirsten K., Neggers, Sebastian J. C. M. M., Pluijm, Saskia M. F., Simmons, Jill H., and Di Iorgi, Natascia
- Published
- 2021
37. Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols
- Author
-
PMC Research, van Atteveld, Jenneke E, de Groot-Kruseman, Hester A, Fiocco, Marta, Lequin, Maarten H, Neggers, Sebastian J C M M, Pluijm, Saskia M F, van der Sluis, Inge M, Pieters, Rob, van den Heuvel-Eibrink, Marry M, PMC Research, van Atteveld, Jenneke E, de Groot-Kruseman, Hester A, Fiocco, Marta, Lequin, Maarten H, Neggers, Sebastian J C M M, Pluijm, Saskia M F, van der Sluis, Inge M, Pieters, Rob, and van den Heuvel-Eibrink, Marry M
- Published
- 2021
38. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function
- Author
-
van der Kooi, Anne-Lotte L F, primary, van Dijk, Marloes, additional, Broer, Linda, additional, van den Berg, Marleen H, additional, Laven, Joop S E, additional, van Leeuwen, Flora E, additional, Lambalk, Cornelis B, additional, Overbeek, Annelies, additional, Loonen, Jacqueline J, additional, van der Pal, Helena J, additional, Tissing, Wim J, additional, Versluys, Birgitta, additional, Bresters, Dorine, additional, Beerendonk, Catharina C M, additional, Ronckers, Cécile R, additional, van der Heiden-van der Loo, Margriet, additional, Kaspers, Gertjan L, additional, de Vries, Andrica C H, additional, Robison, Leslie L, additional, Hudson, Melissa M, additional, Chemaitilly, Wassim, additional, Byrne, Julianne, additional, Berger, Claire, additional, Clemens, Eva, additional, Dirksen, Uta, additional, Falck Winther, Jeanette, additional, Fosså, Sophie D, additional, Grabow, Desiree, additional, Haupt, Riccardo, additional, Kaiser, Melanie, additional, Kepak, Tomas, additional, Kruseova, Jarmila, additional, Modan-Moses, Dalit, additional, Pluijm, Saskia M F, additional, Spix, Claudia, additional, Zolk, Oliver, additional, Kaatsch, Peter, additional, Krijthe, Jesse H, additional, Kremer, Leontien C, additional, Yasui, Yutaka, additional, Brooke, Russell J, additional, Uitterlinden, André G, additional, van den Heuvel-Eibrink, Marry M, additional, and van Dulmen-den Broeder, Eline, additional
- Published
- 2021
- Full Text
- View/download PDF
39. Long-Term Tubular Dysfunction in Childhood Cancer Survivors; DCCSS-LATER 2 Renal Study.
- Author
-
Kooijmans, Esmee C. M., van der Pal, Helena J. H., Pluijm, Saskia M. F., van der Heiden-van der Loo, Margriet, Kremer, Leontien C. M., Bresters, Dorine, van Dulmen-den Broeder, Eline, van den Heuvel-Eibrink, Marry M., Loonen, Jacqueline J., Louwerens, Marloes, Neggers, Sebastian J. C., Ronckers, Cécile, Tissing, Wim J. E., de Vries, Andrica C. H., Kaspers, Gertjan J. L., Bökenkamp, Arend, and Veening, Margreet A.
- Subjects
NEPHROTOXICOLOGY ,CARBOPLATIN ,CROSS-sectional method ,MULTIVARIATE analysis ,KIDNEY tubules ,CASE-control method ,IFOSFAMIDE ,KIDNEY diseases ,RISK assessment ,TUMORS in children ,CANCER patients ,DISEASE prevalence ,CISPLATIN ,LONGITUDINAL method - Abstract
Simple Summary: We studied survivors of childhood cancer who received cancer treatment that might affect the kidneys and compared them to controls from the general population. We investigated if there was a difference in the occurrence of tubular dysfunction. The tubules are the part of the kidney responsible for reabsorption of needed substances to the blood and the removal of wastes. After around 25 years since their cancer diagnosis, we found that in general there were no differences between survivors and controls, but survivors more often had losses of small proteins in the urine. Yet, some survivors of childhood cancer were found to have an increased risk of tubular dysfunction. Namely, survivors treated with the chemotherapeutic agents ifosfamide, cisplatin or carboplatin. Therefore, these patients should be monitored during their follow-up. The aim of this nationwide cross-sectional cohort study was to determine the prevalence of and risk factors for tubular dysfunction in childhood cancer survivors (CCS). In the DCCSS-LATER 2 Renal study, 1024 CCS (≥5 years after diagnosis), aged ≥ 18 years at study, treated between 1963 and 2001 with potentially nephrotoxic therapy (i.e., nephrectomy, abdominal radiotherapy, total body irradiation, cisplatin, carboplatin, ifosfamide, high-dose cyclophosphamide, or hematopoietic stem cell transplantation) participated, and 500 age- and sex-matched participants from Lifelines acted as controls. Tubular electrolyte loss was defined as low serum levels (magnesium < 0.7 mmol/L, phosphate < 0.7 mmol/L and potassium < 3.6 mmol/L) with increased renal excretion or supplementation. A α1-microglobulin:creatinine ratio > 1.7 mg/mmol was considered as low-molecular weight proteinuria (LMWP). Multivariable risk analyses were performed. After median 25.5 years follow-up, overall prevalence of electrolyte losses in CCS (magnesium 5.6%, potassium 4.5%, phosphate 5.5%) was not higher compared to controls. LMWP was more prevalent (CCS 20.1% versus controls 0.4%). LMWP and magnesium loss were associated with glomerular dysfunction. Ifosfamide was associated with potassium loss, phosphate loss (with cumulative dose > 42 g/m
2 ) and LMWP. Cisplatin was associated with magnesium loss and a cumulative dose > 500 mg/m2 with potassium and phosphate loss. Carboplatin cumulative dose > 2800 mg/m2 was associated with potassium loss. In conclusion, long-term tubular dysfunction is infrequent. Yet, ifosfamide, cisplatin and carboplatin are risk factors. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
40. Determinants of impairments in functioning, fatigue, and participation ability in pediatric brain tumor survivors
- Author
-
Verwaaijen, Emma J, primary, Catsman-Berrevoets, Coriene E, additional, Maurice-Stam, Heleen, additional, Dessens, Arianne B, additional, Waslander, Richelle, additional, van den Adel, Tabitha P L, additional, Pluijm, Saskia M F, additional, Reddingius, Roel E, additional, Michiels, Erna, additional, van den Heuvel-Eibrink, Marry M, additional, and Hartman, Annelies, additional
- Published
- 2021
- Full Text
- View/download PDF
41. Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire--a DCCSS LATER study.
- Author
-
Penson, Adriaan, Walraven, Iris, Bronkhorst, Ewald, Grootenhuis, Martha A., Tissing, Wim J. E., van der Pal, Helena J. H., de Vries, Andrica C. H., van den Heuvel-Eibrink, Marry M., Neggers, Sebastian, Versluys, Birgitta A. B., Louwerens, Marloes, Pluijm, Saskia M. F., Blijlevens, Nicole, van der Heiden-van der Loo, Margriet, Kremer, Leontien C. M., van Dulmen-den Broeder, Eline, Knoop, Hans, and Loonen, Jacqueline
- Subjects
PSYCHOMETRICS ,CHILDHOOD cancer ,FATIGUE limit ,CANCER survivors ,PEARSON correlation (Statistics) - Abstract
Background: Fatigue is often reported by patients with childhood cancer both during and after cancer treatment. Several instruments to measure fatigue exist, although none are specifically validated for use in childhood cancer survivors (CCS). The aim of the current study was to present norm values and psychometric properties of the Checklist Individual Strength (CIS) and Short Fatigue Questionnaire (SFQ) in a nationwide cohort of CCS. Methods: In total, 2073 participants were included from the Dutch Childhood Cancer Survivor Study (DCCSS) LATER cohort. Normative data, construct validity, structural validity, and internal consistency were calculated for the CIS and SFQ. In addition, reliability and a cutoff score to indicate severe fatigue were determined for the SFQ. Results: Correlations between CIS/SFQ and vitality measures asking about fatigue were high (>0.8). Correlations between CIS/SFQ and measures of different constructs (sleep, depressive emotions, and role functioning emotional) were moderate (0.4-0.6). Confirmatory factor analysis resulted in a four-factor solution for the CIS and a one-factor solution for the SFQ with Cronbach's alpha for each (sub)scale showing good to excellent values (>0.8). Test-retest reliability of the SFQ was adequate (Pearson's correlation = 0.88; ICC = 0.946; weighted Cohen's kappa item scores ranged 0.31-0.50) and a cut-off score of 18 showed good sensitivity and specificity scores (92.6% and 91.3%, respectively). Conclusion: The current study shows that the SFQ is a good instrument to screen for severe fatigue in CCS. The CIS can be used as a tool to assess the multiple fatigue dimensions in CCS. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
42. Cardiac Disease in Childhood Cancer Survivors: Risk Prediction, Prevention, and Surveillance: JACC CardioOncology State-of-the-Art Review
- Author
-
Leerink, Jan M., de Baat, Esmeé C., Feijen, Elizabeth, Bellersen, Louise, van Dalen, Elvira C., Grotenhuis, Heynric B., Kapusta, Livia, Kok, Waltherus E. M., Loonen, Jacqueline, van der Pal, Heleen J. H., Pluijm, Saskia M. F., Teske, Arco J., Mavinkurve-Groothuis, Annelies M. C., Merkx, Remy, Kremer, Leontine C. M., Amsterdam Reproduction & Development (AR&D), ACS - Heart failure & arrhythmias, CCA - Cancer Treatment and Quality of Life, Graduate School, and Cardiology
- Published
- 2020
43. Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease
- Author
-
Tas, Michelle L, Nagtegaal, Michelle, Kraal, Kathelijne C J M, Tytgat, Godelieve A M, Abeling, Nico G G M, Koster, Jan, Pluijm, Saskia M F, Zwaan, C Michel, de Keizer, Bart, Molenaar, Jan J, van Noesel, Max M, UU BETA RESEARCH, Pediatrics, Graduate School, ARD - Amsterdam Reproduction and Development, AGEM - Endocrinology, metabolism and nutrition, AGEM - Digestive immunity, CCA - Cancer Treatment and Quality of Life, Paediatric Oncology, Laboratory Genetic Metabolic Diseases, and UU BETA RESEARCH
- Subjects
Male ,Spontaneous/pathology ,medicine.medical_specialty ,Neuroblastoma/pathology ,Gastroenterology ,Cohort Studies ,Excretion ,Neuroblastoma ,03 medical and health sciences ,Neoplasm Regression, Spontaneous/pathology ,0302 clinical medicine ,Risk Factors ,Internal medicine ,medicine ,Humans ,Stage (cooking) ,Retrospective Studies ,business.industry ,Infant, Newborn ,Infant ,Retrospective cohort study ,Hematology ,Newborn ,medicine.disease ,Regression ,Oncology ,Neoplasm Regression, Spontaneous ,030220 oncology & carcinogenesis ,Pediatrics, Perinatology and Child Health ,Cohort ,Disease Progression ,Stage 4S Neuroblastoma ,Neoplasm Regression ,Female ,business ,Progressive disease ,030215 immunology - Abstract
BACKGROUND: The clinical course of neuroblastoma stage 4S or MS is characterized by a high rate of spontaneous tumor regression and favorable outcome. However, the clinical course and rate of the regression are poorly understood. METHODS: A retrospective cohort study was performed, including all patients with stage 4S neuroblastoma without MYCN amplification, from two Dutch centers between 1972 and 2012. We investigated the clinical characteristics, the biochemical activity reflected in urinary catecholamine excretion, and radiological imaging to describe the kinetics of tumor regression, therapy response and outcome. RESULTS: The cohort of 31 patients reached a 10-year overall survival of 84% ± 7% (median follow-up 16 years; range, 3.3-39). During the regressive phase, liver size normalized in 91% of the patients and catecholamine excretion in 83%, both after a median of two months (liver size: range, 0-131; catecholamines: range, 0-158). The primary tumors completely regressed in 69% after 13 months (range, 6-73), and the liver architecture normalized in 52% after 15 months (range, 5-131). Antitumor treatment was given in 52% of the patients. Interestingly, regression rates were similar for treated and untreated patients. Four of seven patients < 4 weeks old died of rapid liver expansion and organ compression. Three patients progressed to stage 4, 3 to 13 months after diagnosis; all had persistently elevated catecholamines. CONCLUSION: Patients < 4 weeks old with neuroblastoma stage 4S are at risk of fatal outcome caused by progression of liver metastases. In other patients, tumor regression is characterized by a rapid biochemical normalization that precedes radiological regression.
- Published
- 2019
- Full Text
- View/download PDF
44. Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease
- Author
-
Tas, Michelle L, Nagtegaal, Michelle, Kraal, Kathelijne C J M, Tytgat, Godelieve A M, Abeling, Nico G G M, Koster, Jan, Pluijm, Saskia M F, Zwaan, C Michel, de Keizer, Bart, Molenaar, Jan J, van Noesel, Max M, Tas, Michelle L, Nagtegaal, Michelle, Kraal, Kathelijne C J M, Tytgat, Godelieve A M, Abeling, Nico G G M, Koster, Jan, Pluijm, Saskia M F, Zwaan, C Michel, de Keizer, Bart, Molenaar, Jan J, and van Noesel, Max M
- Abstract
BACKGROUND: The clinical course of neuroblastoma stage 4S or MS is characterized by a high rate of spontaneous tumor regression and favorable outcome. However, the clinical course and rate of the regression are poorly understood.METHODS: A retrospective cohort study was performed, including all patients with stage 4S neuroblastoma without MYCN amplification, from two Dutch centers between 1972 and 2012. We investigated the clinical characteristics, the biochemical activity reflected in urinary catecholamine excretion, and radiological imaging to describe the kinetics of tumor regression, therapy response and outcome.RESULTS: The cohort of 31 patients reached a 10-year overall survival of 84% ± 7% (median follow-up 16 years; range, 3.3-39). During the regressive phase, liver size normalized in 91% of the patients and catecholamine excretion in 83%, both after a median of two months (liver size: range, 0-131; catecholamines: range, 0-158). The primary tumors completely regressed in 69% after 13 months (range, 6-73), and the liver architecture normalized in 52% after 15 months (range, 5-131). Antitumor treatment was given in 52% of the patients. Interestingly, regression rates were similar for treated and untreated patients. Four of seven patients < 4 weeks old died of rapid liver expansion and organ compression. Three patients progressed to stage 4, 3 to 13 months after diagnosis; all had persistently elevated catecholamines.CONCLUSION: Patients < 4 weeks old with neuroblastoma stage 4S are at risk of fatal outcome caused by progression of liver metastases. In other patients, tumor regression is characterized by a rapid biochemical normalization that precedes radiological regression.
- Published
- 2020
45. Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease
- Author
-
UU BETA RESEARCH, Tas, Michelle L, Nagtegaal, Michelle, Kraal, Kathelijne C J M, Tytgat, Godelieve A M, Abeling, Nico G G M, Koster, Jan, Pluijm, Saskia M F, Zwaan, C Michel, de Keizer, Bart, Molenaar, Jan J, van Noesel, Max M, UU BETA RESEARCH, Tas, Michelle L, Nagtegaal, Michelle, Kraal, Kathelijne C J M, Tytgat, Godelieve A M, Abeling, Nico G G M, Koster, Jan, Pluijm, Saskia M F, Zwaan, C Michel, de Keizer, Bart, Molenaar, Jan J, and van Noesel, Max M
- Published
- 2020
46. Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis
- Author
-
de Rotte, Maurits C. F. J., primary, Pluijm, Saskia M. F., additional, de Jong, Pascal H. P., additional, Bulatović Ćalasan, Maja, additional, Wulffraat, Nico M., additional, Weel, Angelique E. A. M., additional, Lindemans, Jan, additional, Hazes, J. M. W., additional, and de Jonge, Robert, additional
- Published
- 2018
- Full Text
- View/download PDF
47. Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis
- Author
-
de Rotte, Maurits C F J, Pluijm, Saskia M F, de Jong, Pascal H P, Bulatović Ćalasan, Maja, Wulffraat, Nico M, Weel, Angelique E A M, Lindemans, Jan, Hazes, J M W, de Jonge, Robert, de Rotte, Maurits C F J, Pluijm, Saskia M F, de Jong, Pascal H P, Bulatović Ćalasan, Maja, Wulffraat, Nico M, Weel, Angelique E A M, Lindemans, Jan, Hazes, J M W, and de Jonge, Robert
- Abstract
OBJECTIVE: The objective was to predict insufficient response to 3 months methotrexate (MTX) in DMARD naïve rheumatoid arthritis patients.METHODS: A Multivariable logistic regression model of rheumatoid arthritis patients starting MTX was developed in a derivation cohort with 285 patients starting MTX in a clinical multicentre, stratified single-blinded trial, performed in seven secondary care clinics and a tertiary care clinic. The model was validated in a validation cohort with 102 patients starting MTX at a tertiary care clinic. Outcome was insufficient response (disease activity score (DAS)28 >3.2) after 3 months of MTX treatment. Clinical characteristics, lifestyle variables, genetic and metabolic biomarkers were determined at baseline in both cohorts. These variables were dichotomized and used to construct a multivariable prediction model with backward logistic regression analysis.RESULTS: The prediction model for insufficient response in the derivation cohort, included: DAS28>5.1, Health Assessment Questionnaire>0.6, current smoking, BMI>25 kg/m2, ABCB1 rs1045642 genotype, ABCC3 rs4793665 genotype, and erythrocyte-folate<750 nmol/L. In the derivation cohort, AUC of ROC curve was 0.80 (95%CI: 0.73-0.86), and 0.80 (95%CI: 0.69-0.91) in the validation cohort. Betas of the prediction model were transformed into total risk score (range 0-8). At cutoff of ≥4, probability for insufficient response was 44%. Sensitivity was 71%, specificity 72%, with positive and negative predictive value of 72% and 71%.CONCLUSIONS: A prognostics prediction model for insufficient response to MTX in 2 prospective RA cohorts by combining genetic, metabolic, clinical and lifestyle variables was developed and validated. This model satisfactorily identified RA patients with high risk of insufficient response to MTX.
- Published
- 2018
48. Gonadal function in boys with newly diagnosed cancer before the start of treatment
- Author
-
Wigny, Kiki M G J, van Dorp, Wendy, van der Kooi, Anne-Lotte L F, de Rijke, Yolanda B, de Vries, Andrica C H, Smit, Marij, Pluijm, Saskia M F, van den Akker, Erica L T, Pieters, Rob, Laven, Joop S E, van den Heuvel-Eibrink, Marry M, Wigny, Kiki M G J, van Dorp, Wendy, van der Kooi, Anne-Lotte L F, de Rijke, Yolanda B, de Vries, Andrica C H, Smit, Marij, Pluijm, Saskia M F, van den Akker, Erica L T, Pieters, Rob, Laven, Joop S E, and van den Heuvel-Eibrink, Marry M
- Published
- 2016
49. Hydrocortisone as an intervention for dexamethasone-induced adverse effects in pediatric patients with acute lymphoblastic leukemia : results of a double-blind, randomized controlled trial
- Author
-
Warris, Lidewij T., Van Den Heuvel-Eibrink, Marry M., Aarsen, Femke K., Pluijm, Saskia M F, Bierings, Marc B., Van Bos, Cor Den, Zwaan, Christian M., Thygesen, Helene H., Tissing, Wim J E, Veening, Margreet A., Pieters, Rob, Van Den Akker, Erica L T, Warris, Lidewij T., Van Den Heuvel-Eibrink, Marry M., Aarsen, Femke K., Pluijm, Saskia M F, Bierings, Marc B., Van Bos, Cor Den, Zwaan, Christian M., Thygesen, Helene H., Tissing, Wim J E, Veening, Margreet A., Pieters, Rob, and Van Den Akker, Erica L T
- Published
- 2016
50. Gonadal function in boys with newly diagnosed cancer before the start of treatment
- Author
-
PMC Research, PMC Medisch specialisten, Child Health, Zorg en O&O, Wigny, Kiki M G J, van Dorp, Wendy, van der Kooi, Anne-Lotte L F, de Rijke, Yolanda B, de Vries, Andrica C H, Smit, Marij, Pluijm, Saskia M F, van den Akker, Erica L T, Pieters, Rob, Laven, Joop S E, van den Heuvel-Eibrink, Marry M, PMC Research, PMC Medisch specialisten, Child Health, Zorg en O&O, Wigny, Kiki M G J, van Dorp, Wendy, van der Kooi, Anne-Lotte L F, de Rijke, Yolanda B, de Vries, Andrica C H, Smit, Marij, Pluijm, Saskia M F, van den Akker, Erica L T, Pieters, Rob, Laven, Joop S E, and van den Heuvel-Eibrink, Marry M
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.